N
NewGLab Pharma Co Ltd
KOSDAQ:214870
NewGLab Pharma Co Ltd
KOSDAQ:214870
Price:
6 915
KRW
-27.44%
Market Cap:
₩439.9m
Income Statement
Earnings Waterfall
NewGLab Pharma Co Ltd
NewGLab Pharma Co Ltd
Income Statement
NewGLab Pharma Co Ltd
NewGLab Pharma Co Ltd
Currency: KRW
| Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||
| Revenue |
58 782
N/A
|
73 465
+25%
|
64 643
-12%
|
50 083
-23%
|
36 911
-26%
|
32 877
-11%
|
35 480
+8%
|
36 599
+3%
|
35 185
-4%
|
30 603
-13%
|
25 390
-17%
|
20 567
-19%
|
19 874
-3%
|
18 640
-6%
|
35 647
+91%
|
61 783
+73%
|
73 253
+19%
|
95 820
+31%
|
88 648
-7%
|
71 390
-19%
|
64 026
-10%
|
54 417
-15%
|
48 287
-11%
|
42 239
-13%
|
39 353
-7%
|
29 354
-25%
|
27 622
-6%
|
25 591
-7%
|
26 580
+4%
|
21 711
-18%
|
18 570
-14%
|
19 077
+3%
|
14 005
-27%
|
12 621
-10%
|
10 954
-13%
|
7 104
-35%
|
6 106
-14%
|
6 295
+3%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(50 780)
|
(64 039)
|
(56 387)
|
(44 373)
|
(33 468)
|
(30 588)
|
(33 354)
|
(34 451)
|
(33 092)
|
(30 377)
|
(26 118)
|
(21 875)
|
(21 233)
|
(18 643)
|
(28 891)
|
(46 131)
|
(51 574)
|
(69 265)
|
(64 724)
|
(54 334)
|
(50 690)
|
(45 170)
|
(41 444)
|
(36 988)
|
(35 108)
|
(26 004)
|
(24 816)
|
(22 456)
|
(21 990)
|
(18 155)
|
(15 662)
|
(16 268)
|
(13 560)
|
(11 666)
|
(10 498)
|
(7 272)
|
(6 911)
|
(6 155)
|
|
| Gross Profit |
8 004
N/A
|
9 426
+18%
|
8 257
-12%
|
5 710
-31%
|
3 441
-40%
|
2 289
-33%
|
2 124
-7%
|
2 147
+1%
|
2 093
-3%
|
226
-89%
|
(729)
N/A
|
(1 309)
-80%
|
(1 361)
-4%
|
(3)
+100%
|
6 755
N/A
|
15 651
+132%
|
21 679
+39%
|
26 555
+22%
|
23 924
-10%
|
17 056
-29%
|
13 336
-22%
|
9 246
-31%
|
6 842
-26%
|
5 250
-23%
|
4 244
-19%
|
3 350
-21%
|
2 806
-16%
|
3 134
+12%
|
4 590
+46%
|
3 556
-23%
|
2 908
-18%
|
2 809
-3%
|
445
-84%
|
955
+115%
|
456
-52%
|
(169)
N/A
|
(805)
-377%
|
140
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(4 075)
|
(5 324)
|
(5 285)
|
(5 119)
|
(4 988)
|
(4 969)
|
(4 939)
|
(5 224)
|
(5 671)
|
(6 222)
|
(6 168)
|
(5 845)
|
(5 247)
|
(5 552)
|
(10 345)
|
(18 402)
|
(24 866)
|
(27 974)
|
(29 920)
|
(27 100)
|
(27 354)
|
(26 675)
|
(29 566)
|
(28 560)
|
(35 184)
|
(31 405)
|
(55 860)
|
(31 086)
|
(30 015)
|
(32 662)
|
(28 814)
|
(24 832)
|
(19 659)
|
(14 679)
|
(13 288)
|
(10 800)
|
(11 028)
|
(6 451)
|
|
| Selling, General & Administrative |
(3 299)
|
(3 779)
|
(4 184)
|
(3 632)
|
(3 406)
|
(3 175)
|
(3 011)
|
(3 147)
|
(3 529)
|
(4 009)
|
(3 972)
|
(3 632)
|
(3 206)
|
(3 757)
|
(8 401)
|
(15 904)
|
(21 003)
|
(23 686)
|
(23 255)
|
(18 984)
|
(16 809)
|
(15 312)
|
(13 750)
|
(13 081)
|
(12 460)
|
(13 610)
|
(13 711)
|
(14 159)
|
(14 443)
|
(13 778)
|
(10 338)
|
(9 788)
|
(7 689)
|
(9 518)
|
(11 206)
|
(9 749)
|
(9 717)
|
(5 175)
|
|
| Research & Development |
(534)
|
(1 060)
|
(760)
|
(1 040)
|
(1 130)
|
(1 322)
|
(1 436)
|
(1 583)
|
(1 641)
|
(1 697)
|
(1 723)
|
(1 643)
|
(1 516)
|
(1 333)
|
(1 273)
|
(1 180)
|
(1 727)
|
(1 885)
|
(2 439)
|
(4 892)
|
(5 642)
|
(7 757)
|
(10 631)
|
(10 019)
|
(10 949)
|
(11 256)
|
(9 910)
|
(11 123)
|
(10 602)
|
(10 976)
|
(11 605)
|
(9 199)
|
0
|
(3 564)
|
(909)
|
(6)
|
(276)
|
(272)
|
|
| Depreciation & Amortization |
(244)
|
(484)
|
(343)
|
(449)
|
(453)
|
(472)
|
(484)
|
(494)
|
(500)
|
(516)
|
(474)
|
(570)
|
(525)
|
(461)
|
(401)
|
(761)
|
(1 353)
|
(1 698)
|
(1 860)
|
(2 450)
|
(2 429)
|
(2 583)
|
(3 098)
|
(3 057)
|
(3 640)
|
(4 230)
|
(4 750)
|
(4 502)
|
(3 954)
|
(3 063)
|
(2 178)
|
(1 446)
|
(956)
|
(803)
|
(651)
|
(568)
|
(386)
|
(271)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(270)
|
(557)
|
(783)
|
(706)
|
(2 366)
|
(773)
|
(2 474)
|
(1 023)
|
(2 086)
|
(2 404)
|
(8 135)
|
(2 309)
|
(27 489)
|
(1 302)
|
(1 016)
|
(4 845)
|
(4 693)
|
(4 398)
|
(11 014)
|
(794)
|
(523)
|
(477)
|
(649)
|
(733)
|
|
| Operating Income |
3 928
N/A
|
4 102
+4%
|
2 972
-28%
|
591
-80%
|
(1 547)
N/A
|
(2 680)
-73%
|
(2 815)
-5%
|
(3 078)
-9%
|
(3 579)
-16%
|
(5 995)
-68%
|
(6 898)
-15%
|
(7 154)
-4%
|
(6 608)
+8%
|
(5 555)
+16%
|
(3 590)
+35%
|
(2 751)
+23%
|
(3 187)
-16%
|
(1 419)
+55%
|
(5 994)
-322%
|
(10 042)
-68%
|
(14 017)
-40%
|
(17 428)
-24%
|
(22 724)
-30%
|
(23 310)
-3%
|
(30 940)
-33%
|
(28 055)
+9%
|
(53 054)
-89%
|
(27 952)
+47%
|
(25 425)
+9%
|
(29 106)
-14%
|
(25 906)
+11%
|
(22 023)
+15%
|
(19 214)
+13%
|
(13 724)
+29%
|
(12 832)
+6%
|
(10 969)
+15%
|
(11 833)
-8%
|
(6 311)
+47%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
174
|
140
|
139
|
166
|
261
|
687
|
349
|
421
|
376
|
(437)
|
(478)
|
(527)
|
(978)
|
(794)
|
(425)
|
(7 189)
|
(6 663)
|
(1 171)
|
(1 686)
|
2 410
|
1 298
|
(4 589)
|
(2 610)
|
(569)
|
198
|
975
|
(616)
|
(4 146)
|
(2 842)
|
(7 232)
|
(10 648)
|
(8 680)
|
(12 058)
|
(7 531)
|
(4 866)
|
(4 261)
|
(2 585)
|
(205)
|
|
| Non-Reccuring Items |
(38)
|
(88)
|
(95)
|
(97)
|
(71)
|
(23)
|
(13)
|
(114)
|
(117)
|
(121)
|
(378)
|
(74)
|
(127)
|
(531)
|
0
|
0
|
0
|
(1 806)
|
0
|
(1 792)
|
0
|
(1 077)
|
0
|
(5 135)
|
0
|
(24 983)
|
0
|
(19 702)
|
(18 942)
|
(5 488)
|
(5 615)
|
(8 446)
|
(9 208)
|
(1 738)
|
(1 611)
|
(3)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
(2)
|
14
|
13
|
119
|
103
|
0
|
86
|
(20)
|
(7)
|
0
|
(21)
|
(21)
|
(439)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(126)
|
0
|
0
|
0
|
(151)
|
0
|
0
|
(84)
|
123
|
74
|
55
|
(26)
|
4 530
|
4 720
|
4 884
|
5 443
|
833
|
|
| Total Other Income |
(39)
|
58
|
57
|
331
|
211
|
108
|
242
|
70
|
68
|
(1 454)
|
(1 361)
|
(1 545)
|
(1 587)
|
(444)
|
(1 201)
|
(914)
|
(283)
|
340
|
479
|
460
|
(24)
|
(225)
|
(336)
|
(461)
|
(545)
|
(1 665)
|
(1 886)
|
(2 069)
|
(2 127)
|
(32 686)
|
(35 928)
|
(34 451)
|
(21 157)
|
18 433
|
21 784
|
20 716
|
7 319
|
1 151
|
|
| Pre-Tax Income |
4 025
N/A
|
4 209
+5%
|
3 088
-27%
|
1 005
-67%
|
(1 025)
N/A
|
(1 805)
-76%
|
(2 237)
-24%
|
(2 614)
-17%
|
(3 272)
-25%
|
(8 014)
-145%
|
(9 115)
-14%
|
(9 320)
-2%
|
(9 319)
+0%
|
(7 763)
+17%
|
(5 216)
+33%
|
(10 854)
-108%
|
(10 133)
+7%
|
(4 057)
+60%
|
(7 203)
-78%
|
(8 966)
-24%
|
(12 745)
-42%
|
(23 444)
-84%
|
(25 669)
-9%
|
(29 475)
-15%
|
(31 286)
-6%
|
(53 879)
-72%
|
(55 556)
-3%
|
(53 869)
+3%
|
(49 421)
+8%
|
(74 389)
-51%
|
(78 023)
-5%
|
(73 545)
+6%
|
(61 664)
+16%
|
(29)
+100%
|
7 196
N/A
|
10 367
+44%
|
(1 655)
N/A
|
(4 533)
-174%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(869)
|
(841)
|
(607)
|
(161)
|
272
|
716
|
814
|
(148)
|
(265)
|
(1 101)
|
(986)
|
(64)
|
(31)
|
401
|
240
|
560
|
0
|
51
|
(42)
|
277
|
0
|
836
|
0
|
(4)
|
(4)
|
1 956
|
2 016
|
2 228
|
2 287
|
2 432
|
2 373
|
2 320
|
0
|
933
|
0
|
933
|
933
|
0
|
|
| Income from Continuing Operations |
3 156
|
3 369
|
2 481
|
843
|
(754)
|
(1 089)
|
(1 424)
|
(2 762)
|
(3 537)
|
(9 115)
|
(10 102)
|
(9 385)
|
(9 351)
|
(7 362)
|
(4 975)
|
(10 292)
|
(9 610)
|
(4 006)
|
(7 244)
|
(8 689)
|
(12 468)
|
(22 609)
|
(24 834)
|
(29 479)
|
(31 291)
|
(51 923)
|
(53 540)
|
(51 641)
|
(47 133)
|
(71 957)
|
(75 650)
|
(71 225)
|
(59 402)
|
904
|
8 129
|
11 301
|
(722)
|
(4 533)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
262
|
349
|
1 412
|
1 429
|
1 216
|
1 233
|
2 407
|
2 466
|
2 443
|
2 493
|
1 088
|
1 044
|
889
|
1 012
|
571
|
|
| Net Income (Common) |
3 156
N/A
|
3 362
+7%
|
2 474
-26%
|
836
-66%
|
(761)
N/A
|
(1 089)
-43%
|
(1 424)
-31%
|
(2 762)
-94%
|
(3 537)
-28%
|
(9 115)
-158%
|
(10 102)
-11%
|
(9 385)
+7%
|
(9 351)
+0%
|
(7 362)
+21%
|
(4 975)
+32%
|
(10 292)
-107%
|
(9 610)
+7%
|
(4 006)
+58%
|
(7 244)
-81%
|
(8 689)
-20%
|
(12 468)
-43%
|
(22 609)
-81%
|
(24 834)
-10%
|
(29 218)
-18%
|
(30 942)
-6%
|
(50 511)
-63%
|
(52 111)
-3%
|
(50 425)
+3%
|
(45 901)
+9%
|
(69 550)
-52%
|
(73 184)
-5%
|
(68 782)
+6%
|
(56 909)
+17%
|
1 991
N/A
|
9 174
+361%
|
12 189
+33%
|
290
-98%
|
(3 962)
N/A
|
|
| EPS (Diluted) |
315.6
N/A
|
336.2
+7%
|
206.16
-39%
|
69.66
-66%
|
-63.41
N/A
|
-90.75
-43%
|
-118.66
-31%
|
-230.16
-94%
|
-294.75
-28%
|
-759.58
-158%
|
-777.07
-2%
|
-670.35
+14%
|
-623.4
+7%
|
-490.8
+21%
|
-331.66
+32%
|
-343.06
-3%
|
-384.4
-12%
|
-190.76
+50%
|
-289.76
-52%
|
-334.19
-15%
|
-445.28
-33%
|
-837.37
-88%
|
-832.56
+1%
|
-965.02
-16%
|
-1 013.76
-5%
|
-8 312.2
-720%
|
-1 664.37
+80%
|
-1 609.69
+3%
|
-1 459.5
+9%
|
-11 006.85
-654%
|
-2 209.77
+80%
|
-2 076.37
+6%
|
-1 717.96
+17%
|
300
N/A
|
1 324.6
+342%
|
1 840.42
+39%
|
31.05
-98%
|
-446.31
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
